Pathstone Family Office’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $4.67M | Buy |
51,058
+11,320
| +28% | +$1.03M | 0.04% | 284 |
|
|
2023
Q2 | $3.26M | Sell |
39,738
-4,120
| -9% | -$338K | 0.05% | 230 |
|
|
2023
Q1 | $3.51M | Sell |
43,858
-65,586
| -60% | -$5.25M | 0.06% | 191 |
|
|
2022
Q4 | $6.54M | Sell |
109,444
-7,212
| -6% | -$431K | 0.06% | 234 |
|
|
2022
Q3 | $5.86M | Buy |
116,656
+77,252
| +196% | +$3.88M | 0.05% | 210 |
|
|
2022
Q2 | $2.2M | Buy |
39,404
+7,574
| +24% | +$422K | 0.05% | 199 |
|
|
2022
Q1 | $1.81M | Buy |
31,830
+2,334
| +8% | +$133K | 0.04% | 189 |
|
|
2021
Q4 | $1.65M | Buy |
29,496
+6,676
| +29% | +$374K | 0.04% | 224 |
|
|
2021
Q3 | $1.1M | Buy |
22,820
+13,932
| +157% | +$669K | 0.03% | 267 |
|
|
2021
Q2 | $372K | Buy |
+8,888
| New | +$372K | 0.01% | 570 |
|
|
2021
Q1 | – | Sell |
-572
| Closed | -$20K | – | 1110 |
|
|
2020
Q4 | $20K | Buy |
+572
| New | +$20K | ﹤0.01% | 686 |
|
|
2020
Q3 | – | Sell |
-5,000
| Closed | -$164K | – | 947 |
|
|
2020
Q2 | $164K | Sell |
5,000
-4,940
| -50% | -$162K | 0.02% | 182 |
|
|
2020
Q1 | $300K | Buy |
+9,940
| New | +$300K | 0.04% | 131 |
|
|
2019
Q2 | – | Sell |
-700
| Closed | -$18K | – | 813 |
|
|
2019
Q1 | $18K | Buy |
+700
| New | +$18K | ﹤0.01% | 440 |
|
|
2018
Q2 | – | Sell |
-440
| Closed | -$11K | – | 272 |
|
|
2018
Q1 | $11K | Buy |
+440
| New | +$11K | 0.01% | 217 |
|
|
2017
Q3 | – | Sell |
-700
| Closed | -$15K | – | 290 |
|
|
2017
Q2 | $15K | Hold |
700
| – | – | 0.01% | 292 |
|
|
2017
Q1 | $12K | Buy |
+700
| New | +$12K | 0.01% | 271 |
|
|
2016
Q4 | – | Sell |
-1,000
| Closed | -$21K | – | 171 |
|
|
2016
Q3 | $21K | Hold |
1,000
| – | – | 0.02% | 92 |
|
|
2016
Q2 | $27K | Buy |
+1,000
| New | +$27K | 0.03% | 76 |
|